indirubin

靛玉红

Report date: 2022/08/17 14:10:34

Base Information

Drug Nameindirubin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsLeukemia, Myelogenous, Chronic
Approved Indications in ChinaLeukemia, Myelogenous, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Pharmaceutical Research Institute Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A